Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N288435-5mg | 5mg | In stock | $68.90 | |
N288435-10mg | 10mg | In stock | $107.90 | |
N288435-25mg | 25mg | In stock | $243.90 | |
N288435-50mg | 50mg | In stock | $286.90 | |
N288435-100mg | 100mg | In stock | $484.90 |
Oligosaccharyltransferase (OST) inhibitor; anti-flaviviral
Synonyms | 5-[(Dimethylamino)sulfonyl]-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide | NCGC00351072-01 | KSC-367-096-1 | KUC113535N-02 | ZB1632 | HY-117383 | NGI1 | NGI-1 | HMS3081P23 | EX-A2753 | NGI 1 | s8750 | KUC113535N | BN164083 | NGI1; NGI 1; ML414; ML |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Oligosaccharyltransferase (OST) inhibitor; anti-flaviviral. Inhibits dengue, Zika, West Nile, and yellow fever viruses by blocking viral RNA replication (EC50values are 0.85 and 2.2 μM for DENV and ZIKV inhibition, respectively). Selectively arrests proli |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | Description: NGI-1 is a a cell-permeable inhibitor of oligosaccharyltransferase (OST).can effectively reduce virus infectivity without affecting cell viability. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-pyrrolidin-1-ylbenzamide |
---|---|
INCHI | InChI=1S/C17H22N4O3S2/c1-12-11-18-17(25-12)19-16(22)14-10-13(26(23,24)20(2)3)6-7-15(14)21-8-4-5-9-21/h6-7,10-11H,4-5,8-9H2,1-3H3,(H,18,19,22) |
InChi Key | QPKGRLIYJGBKJL-UHFFFAOYSA-N |
Canonical SMILES | CC1=CN=C(S1)NC(=O)C2=C(C=CC(=C2)S(=O)(=O)N(C)C)N3CCCC3 |
Isomeric SMILES | CC1=CN=C(S1)NC(=O)C2=C(C=CC(=C2)S(=O)(=O)N(C)C)N3CCCC3 |
PubChem CID | 2519269 |
Molecular Weight | 394.51 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2218274 | Certificate of Analysis | Jun 17, 2022 | N288435 |
H2218275 | Certificate of Analysis | Jun 17, 2022 | N288435 |
H2218277 | Certificate of Analysis | Jun 17, 2022 | N288435 |
H2218278 | Certificate of Analysis | Jun 17, 2022 | N288435 |
H2218279 | Certificate of Analysis | Jun 17, 2022 | N288435 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 39.45, Max Conc. mM: 100 |
---|
Signal | Warning |
---|---|
Hazard Statements | H303:May be harmful if swallowed |
RIDADR | NONHforallmodesoftransport |